0001654954-18-000192.txt : 20180108 0001654954-18-000192.hdr.sgml : 20180108 20180108174445 ACCESSION NUMBER: 0001654954-18-000192 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180108 FILED AS OF DATE: 20180108 DATE AS OF CHANGE: 20180108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robinson Chandler CENTRAL INDEX KEY: 0001727334 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55866 FILM NUMBER: 18517385 MAIL ADDRESS: STREET 1: C/O SKOKIE BLVD., SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 5 REVERE DRIVE, SUITE 200 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: 6143958936 MAIL ADDRESS: STREET 1: 5 REVERE DRIVE, SUITE 200 CITY: NORTHBROOK STATE: IL ZIP: 60062 3 1 section16.xml PRIMARY DOCUMENT X0206 3 2018-01-08 0 0001645469 Monopar Therapeutics NONE 0001727334 Robinson Chandler C/O SKOKIE BLVD., SUITE 350 WILMETTE IL 60091 true true true Chief Executive Officer Common stock 14002.8 D Common stock 4111272.88 I See Footnote (1) Common stock 166667 I See Footnote (2) Stock options 0.001 Common stock 84000 D Stock options 0.001 Common stock 84000 D This is based upon the 4,111,272.88 shares of Monopar Common Stock that Tactic Pharma LLC indirectly controls through TacticGem LLC. As a manager of Tactic Pharma LLC, Dr. Robinson may be deemed to share voting and dispositive power over these 4,111,272.88 shares. Dr. Robinson disclaims beneficial ownership of the 4,111,272.88 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein. This is based upon the 166,667 shares of Monopar Common Stock that Tactic Pharma LLC directly owns. As a manager of Tactic Pharma LLC, Dr. Robinson may be deemed to share voting and dispositive power over these 166,667 shares. Dr. Robinson disclaims beneficial ownership of the 166,667 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein. Reflects the issuance of options to purchase up to 84,000 shares of common stock granted to Dr. Robinson on April 4, 2016 for his services as a director and officer of Monopar Therapeutics. The options vested 50% upon grant date, 25% upon the 6-month anniversary of grant date, and 25% upon the 1-year anniversary of grant date. The options each expire on April 3, 2026. Reflects the issuance of options to purchase up to 84,000 shares of common stock granted to Dr. Robinson on February 20, 2017 for his services as a director and officer of Monopar Therapeutics. The options will vest 6/48ths at the six-month anniversary of grant date and 1/48th per month thereafter. The options each expire on February 19, 2027. /s/ Kim R. Tsuchimoto, Attorney-in-fact 2018-01-08 EX-24 2 poarob.htm POWER OF ATTORNEY Blueprint
 
 
MONOPAR THERAPEUTICS INC.
CONFIRMING STATEMENT
REGARDING AUTHORITY TO EXECUTE SECTION 16(a) REPORTS
 
 
This Statement confirms that the undersigned, Chandler Robinson, M.D. c/o Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350, Wilmette, IL 60091 (the “Insider”), has authorized and designated Kim R. Tsuchimoto of Monopar Therapeutics Inc. (the “Company”), Ashley Graffeo and Robert Rupp, Esq. of Baker & Hostetler LLP, the Company’s United States legal counsel, and each of them (each of the foregoing is referred to as an “Authorized Signer”) to execute and file on the Insider’s behalf a Form ID and any and all Forms 3, 4 and 5 (including any amendments thereto) that the Insider may be required to file with the United States Securities and Exchange Commission under Section 16(a) of the Securities Exchange Act of 1934, as a result of the Insider’s ownership of, or transactions in, securities of the Company. The authority of the Authorized Signers under this Confirming Statement shall continue until the Insider is no longer required to file Forms 3, 4 and 5 with regard to the Insider’s ownership of, or transactions in, securities of the Company, unless earlier revoked in writing. The Insider acknowledges that none of the Authorized Signers is assuming any of the Insider’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
 
/s/ Chandler Robinson
---------------------------------------
Chandler Robinson, M.D.